Microbot Medical is making headlines with promising early results from its U.S. clinical trial of the Liberty™ Robotic Surgical System. The first five peripheral vascular procedures were successfully completed with zero device-related adverse events—underscoring the system’s potential to transform endovascular procedures. “This is a critical milestone in our journey toward FDA clearance,” said CEO Harel Gadot, as the company continues building momentum toward commercialization.
In a bold move to accelerate its digital and AI innovation strategy, GE HealthCare has appointed Tamer Bankes as its new Chief Technology Officer. With a proven track record at Nike and Whirlpool, Bankes brings extensive expertise in software and product development that is expected to drive the company’s next chapter of tech-powered growth.
On the startup front, Puzzle Medical Devices is turning heads with a $30 million Series A funding round. Focused on developing a groundbreaking transcatheter heart pump for patients with advanced heart failure, the Montreal-based company plans to use the funding to advance clinical trials and expand U.S. operations. CEO Ali Toloui called the investment “a pivotal step” toward delivering less invasive, life-saving care.
